search
Back to results

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Primary Purpose

Parkinson's Disease, Malignant Melanoma

Status
Completed
Phase
Locations
Study Type
Observational
Intervention
Sponsored by
Teva Branded Pharmaceutical Products R&D, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an observational trial for Parkinson's Disease

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment Exclusion Criteria: unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Arm Label

    Observational procedure

    Arm Description

    Patients will be examined and any suspicious skin abnormalities will be biopsied

    Outcomes

    Primary Outcome Measures

    Secondary Outcome Measures

    Full Information

    First Posted
    September 13, 2005
    Last Updated
    October 14, 2010
    Sponsor
    Teva Branded Pharmaceutical Products R&D, Inc.
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00203008
    Brief Title
    A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
    Official Title
    A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients
    Study Type
    Observational

    2. Study Status

    Record Verification Date
    October 2010
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2003 (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    September 2003 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Teva Branded Pharmaceutical Products R&D, Inc.

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Parkinson's Disease, Malignant Melanoma

    7. Study Design

    Enrollment
    2106 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Observational procedure
    Arm Description
    Patients will be examined and any suspicious skin abnormalities will be biopsied

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment Exclusion Criteria: unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product
    Study Population Description
    Patients known to have Parkinson's Disease will be invited to join the study by their treating physicians as long as they are not taking investigational product.
    Sampling Method
    Non-Probability Sample
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Bruce Schwartz, Ph.D.
    Organizational Affiliation
    Teva Neuroscience, Inc.
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

    We'll reach out to this number within 24 hrs